Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Six universities including Oxford have been awarded a total of £4.3m by the Medical Research Council (MRC) to grow and develop the UK’s research base in dementia science.

Zam Cader, leader of the Oxford Momentum Award

The Momentum awards, designed to support the UK Dementia Research Institute (DRI), will help open new research avenues which could transform the potential of dementia research in the UK. The awards represent the first steps in establishing the capabilities for the DRI, which is being funded through a combined investment of £250m from the MRC and founding charity partners, the Alzheimer’s Society and Alzheimer’s Research UK. The DRI is expected to be up and running by 2019.

The DRI will be the biggest single investment into dementia research the UK has ever seen and we are proud to start building the foundation for it now. These transformative awards will create exciting new opportunities across the dementia research landscape and provide impetus to allow the Institute to start making its mark as soon as it is launched.
- Dr Rob Buckle, director of science programmes at the MRC

Each award will enhance overall dementia research capacity in the UK and, crucially, will accelerate the recruitment of research leaders and ‘rising stars’ from both within and outside of the UK. The funding will also help current researchers develop promising connections between different research disciplines to bring new understanding to the field, as well as exploit emerging scientific opportunities and explore new approaches to fight the disease.

The Oxford Momentum Award is led by Zam Cader, who will be developing methods to better understand the epigenetics of microglia interactions in dementia. The other project leads for this multi-disciplinary programme are Sally Crowley, Francesca Nicholls, Florian Plattner and Caleb Webber.  The four projects are designed to develop key capabilities in the provision of human brain cell types, cell imaging analysis and targeting signalling pathways, and will include recruitment back to the UK of a researcher who currently holds a faculty appointment in the US.

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'